SAFETY AND EFFICACY OF EPLERENONE IN PATIENTS AT HIGH RISK FOR HYPERKALEMIA AND/OR WORSENING RENAL FUNCTION. ANALYSES OF THE EMPHASIS-HF STUDY SUBGROUPS (EPLERENONE IN MILD PATIENTS HOSPITALIZATION AND SURVIVAL STUDY IN HEART FAILURE)
Translation articles:<p>R. Eschalier, J.J.V. McMurray, K. Swedberg, D.J. van Veldhuisen, H. Krum, S.J. Pocock, H. Shi, J. Vincent, P. Rossignol, F. Zannad, B. Pitt, for the EMPHASIS-HF Investigators "Safety and Efficacy of Eplerenone in Patients at High Risk for Hyperkalemia and/or Worsen...
Saved in:
Main Authors: | R. Eschalier (Author), J.J.V. McMurray (Author), K. Swedberg (Author), D.J. Veldhuisen van (Author), H. Krum (Author), S.J. Pocock (Author), H. Shi (Author), J. Vincent (Author), P. Rossignol (Author), F. Zannad (Author), B. Pitt (Author) |
---|---|
Format: | Book |
Published: |
Столичная издательская компания,
2015-09-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
SAFETY AND EFFICACY OF EPLERENONE IN PATIENTS AT HIGH RISK FOR HYPERKALEMIA AND/OR WORSENING RENAL FUNCTION. ANALYSES OF THE EMPHASIS-HF STUDY SUBGROUPS (EPLERENONE IN MILD PATIENTS HOSPITALIZATION AND SURVIVAL STUDY IN HEART FAILURE)
by: R. Eschalier, et al.
Published: (2015) -
New Clinical Aspects of Eplerenone Use in Clinical Practice
by: S. R. Gilyarevskiy, et al.
Published: (2018) -
Eplerenone nanocrystals engineered by controlled crystallization for enhanced oral bioavailability
by: Muhammad Ayub Khan, et al.
Published: (2021) -
A SELECTIVE ANTAGONIST OF MINERALOCORTICOID RECEPTOR EPLERENONE IN CARDIOLOGY PRACTICE
by: B. B. Gegenava, et al.
Published: (2015) -
A SELECTIVE ANTAGONIST OF MINERALOCORTICOID RECEPTOR EPLERENONE IN CARDIOLOGY PRACTICE
by: B. B. Gegenava, et al.
Published: (2015)